Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chemoimmunotherapy

Chemotherapy combined with immunotherapy. Chemotherapy uses different drugs to kill or slow the growth of cancer cells; immunotherapy uses treatments… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Despite promising results with targeted drugs, chemoimmunotherapy with fludarabine, cyclophosphamide (FC), and rituximab (R… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Hemophagocytic lymphohistiocytosis (HLH) used to have a dismal prognosis. We report the final results of HLH-94, the largest… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Antitumor immune response and chemotherapy-induced immunomodulation in colon cancer patients represented the rationale to design… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The adverse prognosis of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia (ALL… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Building on the prior work of use of pentostatin in chronic lymphocytic leukemia (CLL), we initiated a trial of combined… Expand
  • table 1
  • table 2
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Adult Burkitt-type lymphoma (BL) and acute lymphoblastic leukemia (B-ALL) are rare entities composing 1% to 5% of non… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Fludarabine and cyclophosphamide (FC), which are active in treatment of chronic lymphocytic leukemia (CLL), are… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE The efficacy, toxicity, and tolerability of chemoimmunotherapy with the combination of fludarabine, cyclophosphamide, and… Expand
Is this relevant?